Pillstats
Rx only · Tablet, Film Coated · Oral

Eplerenone

Brands: Inspra · Eplerenone

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)298869
US makers7 labelers
Packages27
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 22 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.06$8.11$12.17$16.22Aug 2025Mar 2026Jul 2026
$0.999
Latest avg · Jul 22, 2026
-93%
Since Aug 20, 2025
6
Active US suppliers
56%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.9K14K21K28K2025 Q12025 Q22025 Q32025 Q42026 Q1
23K
Rx · 2026 Q1
1.3M
Units dispensed
+14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Mylan Pharmaceuticals Inc.unknown8SUPPLYING
Breckenridge Pharmaceutical, Inc.unknown6SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
Accord Healthcare Inc.unknown4SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
American Health Packagingunknown1SUPPLYING
Viatris Specialty LLCunknown2EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.